Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EAHAD 2026: Nine-Year Outcomes of Gene Therapy
February 2026
Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.
Read more
11
Mins
2 Sep 2022
Gene Therapy in Haemophilia: Updates from Clinical Trials and Insights to Future Technologies
At the International Society on Thrombosis and Haemostasis (ISTH) 2022 Congress, held 9th–13th July, multiple oral and poster presentations were dedicated to gene therapy as a treatment for haemophilia A or B.
20 Aug 2022
Increasing Awareness in Beta-Thalassemia
This series of webinars focusses on Beta-Thalassemia. These are scientific presentations and discussions for the purpose of scientific exchange.
16 Aug 2022
Is Complete Response Enough? An Expert Look Towards the Future of Higher-Risk MDS Treatment
This satellite symposium discusses current key topics in higher-risk MDS, including treatment outcome measures
4 Aug 2022
Laying the Foundation Towards Long-Term Survival in Patients with High-Risk Acute Myeloid Leukaemia
For many patients diagnosed with acute myeloid leukaemia (AML), long-term survival remains elusive….
21 Jul 2022
New Treatment Options in Paediatric Thalassemia
The third of our six-part series focuses on new treatment options in paediatric thalassemia with expert Dr Immacolata Tartaglione, paediatrician at University of Campania Luigi Vanvitelli in Napoli, Italy.
5
Mins
21 Jul 2022
EHA 2022 Abstract Highlights
The following highlights focus on several insightful and innovative abstracts at the European Hematology Association (EHA) 2022 hybrid…
3
Mins
21 Jul 2022
Zamtocabtagene Autoleucel (MB-CART2019.1): An Investigational CAR-T Cell Product with Tandem Targeting of CD19 and CD20 as a Potential Treatment Option for Patients with Relapsed/ Refractory B Cell Non-Hodgkin Lymphoma
Presenting at the European Hematology Association (EHA) 2022 Congress, Peter Borchmann from the University of Cologne, Germany…
6
Mins
21 Jul 2022
Exploring a Role for Mitapivat in Children with Pyruvate Kinase Deficiency
Three posters presented at the European Hematology Association (EHA) 2022 Hybrid Congress focused on the role of mitapivat in the…
Loading posts...
« Previous
1
…
56
57
58
59
60
…
100
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View